Oncology Today with Dr Neil Love  By  cover art

Oncology Today with Dr Neil Love

By: Research To Practice
  • Summary

  • Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.
    © 2024 Dr Neil Love
    Show more Show less
Episodes
  • Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition
    May 6 2024
    Dr Matthew D Galsky from Icahn School of Medicine at Mount Sinai in New York, New York, summarizes treatment options for patients with HER2-altered genitourinary cancers and reviews recent emerging clinical trial data in the field, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayHER2PanTumor23/3GU).
    Show more Show less
    1 hr and 7 mins
  • Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer
    May 3 2024
    Prof Eric Van Cutsem from University Hospitals Leuven in Leuven, Belgium, discusses recent updates on available and novel treatment strategies for gastroesophageal cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/YiR2023/Gastroesophageal2).
    Show more Show less
    1 hr
  • Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series
    May 1 2024
    Dr Ruben A Mesa from Wake Forest University School of Medicine in Winston-Salem, North Carolina, discusses recent updates on available and novel treatment strategies for myelofibrosis, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/MTPMF23/Part2).
    Show more Show less
    1 hr and 1 min

What listeners say about Oncology Today with Dr Neil Love

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.